Loading...

BAX BAXTER INTERNATIONAL INC Disposals and divestitures 8-K Filing

BXTR

BX

BAXTER INTERNATIONAL INC

(BAX)

2025 8-K

Bond Issuance Details

Credit Agreement Amendment

Tender Offer Increase

Tender Offer Announcement

Executive Departure

Earnings Report Filing

Management Change

Financial Statements

Debt-Equity Swaps

Earnings Releases

Stockholder Engagement

Earnings Release

Kidney Care Sale

Management Change

Bylaw Amendments

Board Resignation

Earnings Release

Kidney Care Sale

Hurricane Impact

Hurricane Relief Update

Board Appointment

Management Changes

Earnings Release

Credit Agreement for Term L...

Departure of Directors or C...

Earnings Release

Credit Agreements Amendment

Update on Separation of Kid...

Earnings Release

Earnings Release

Appointment of Chief Financ...

Appointment and Resignation

Earnings Release

Appointment of Director

Equity Purchase Agreement a...

Earnings Release

Credit Agreements Amendment

Director and Executive Changes

Earnings Release

Resignation and Strategic A...

External Links:

Baxter International Inc. completed the sale of its Kidney Care business for $3.80 billion, receiving approximately $3.71 billion in cash after adjustments, and this filing includes pro forma financial information reflecting the sale's impact.

AI Assistant

BAXTER INTERNATIONAL INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.